JP2024527043A5 - - Google Patents

Info

Publication number
JP2024527043A5
JP2024527043A5 JP2024504950A JP2024504950A JP2024527043A5 JP 2024527043 A5 JP2024527043 A5 JP 2024527043A5 JP 2024504950 A JP2024504950 A JP 2024504950A JP 2024504950 A JP2024504950 A JP 2024504950A JP 2024527043 A5 JP2024527043 A5 JP 2024527043A5
Authority
JP
Japan
Prior art keywords
sequence
seq
variable region
chain variable
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527043A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074284 external-priority patent/WO2023010098A2/en
Publication of JP2024527043A publication Critical patent/JP2024527043A/ja
Publication of JP2024527043A5 publication Critical patent/JP2024527043A5/ja
Pending legal-status Critical Current

Links

JP2024504950A 2021-07-28 2022-07-28 新規多重特異性分子 Pending JP2024527043A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/109028 2021-07-28
CN2021109028 2021-07-28
CNPCT/CN2022/103725 2022-07-04
CN2022103725 2022-07-04
PCT/US2022/074284 WO2023010098A2 (en) 2021-07-28 2022-07-28 Novel multi-specific molecules

Publications (2)

Publication Number Publication Date
JP2024527043A JP2024527043A (ja) 2024-07-19
JP2024527043A5 true JP2024527043A5 (https=) 2025-08-04

Family

ID=85088266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504950A Pending JP2024527043A (ja) 2021-07-28 2022-07-28 新規多重特異性分子

Country Status (10)

Country Link
US (1) US20240336686A1 (https=)
EP (1) EP4377357A4 (https=)
JP (1) JP2024527043A (https=)
KR (1) KR20240039005A (https=)
CN (1) CN118055946A (https=)
AU (1) AU2022319934A1 (https=)
CA (1) CA3226306A1 (https=)
MX (1) MX2024001328A (https=)
TW (1) TW202311296A (https=)
WO (1) WO2023010098A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3196930A1 (en) * 2020-09-28 2022-03-31 Elpiscience (Suzhou) Biopharma, Ltd. Novel anti-claudin18 antibodies
CN120569409A (zh) * 2023-01-18 2025-08-29 科望(苏州)生物医药科技有限公司 靶向sirpa和claudin 18.2的双特异性分子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018223182A1 (en) * 2017-06-05 2018-12-13 The Council Of The Queensland Institute Of Medical Research A combination of, or a bispecific binding molecule to, an immune checkpoint molecule antagonist and a rank-l (nf- kb ligand) antagonist for cancer therapy or prophylaxis and uses therefor.

Similar Documents

Publication Publication Date Title
JP6779299B2 (ja) 抗ｐｄ−ｌ１抗体およびその使用
JP2020501531A5 (https=)
JP2022515318A5 (https=)
JP2021514664A5 (https=)
JP2021534802A5 (https=)
JP2021506244A5 (https=)
JP2024531900A5 (https=)
AU2019382505B2 (en) Anti-PD-1 antibodies and uses thereof
US20250051467A1 (en) Fap/cd40 binding molecule and medicinal use thereof
JP2025503322A5 (https=)
JP2024527043A5 (https=)
WO2022098771A1 (en) Multispecific antibodies and uses thereof
JP2022527173A5 (https=)
WO2020089794A1 (en) Methods of treating cancer
WO2023060277A1 (en) Composition of multispecific antibodies targeting cdh17-expressing tumors and method of making and using thereof
CA3091502A1 (en) Anti-pd-1 antibodies and uses thereof
TW202221035A (zh) 抗ilt2抗體及其用途
KR20240055080A (ko) Pd-1에 특이적으로 결합하는 단백질 및 그의 약학적 용도
CN118076638A (zh) 新型抗sirpa抗体
JP2025503513A5 (https=)
WO2024088346A1 (en) Anti-ccr8 antibodies and uses thereof
WO2024114676A1 (zh) Cldn18.2/4-1bb结合蛋白及其医药用途
JP2023525991A5 (https=)
JP2025513588A5 (https=)
WO2023151661A1 (zh) 免疫缀合物及其用途